publicações selecionadas
-
artigo académico
- Selective Cytotoxicity of Portuguese Propolis Ethyl Acetate Fraction towards Renal Cancer Cells. Biomolecules. 2022
- Imidazolylpyrrolone-based small molecules as anticancer agents for renal cell carcinoma. Chemistry - A European Journal. 2022
-
documento
- New substituted 3,5-dihydro-4H-chromeno [2,3-d] pyrimidin4-one: a promising strategy for breast cancer treatment 2020
- New chromene derivatives: unravelling the molecular mechanisms for breast cancer treatment 2019
- Synthesis of imidazole derivatives and evaluation of the anticancer potential on renal cell carcinoma 2019
- Chromene derivatives: a new strategy to overcome renal cancer resistance 2019
- Exploitation of novel chromene derivatives for breast cancer treatment 2019
- Synthesis and biological activity of new anticancer agents for breast cancer treatment 2019
- New chromene-based molecules for renal cell cancer therapy 2019
- New chromene derivatives: Unraveling the molecular mechanisms for breast cancer therapy 2019
- Chromene-based compounds as candidates for renal cell cancer treatment 2019
- Biological activity of novel targeted inhibitors for renal cell cancer therapy 2019
- In vitro and in vivo evaluation of new chromene derivatives as potent anticancer agents 2019
- Synthesis of imidazo-pyridine derivatives for mTOR inhibition 2019
- Chromene-based molecules as targeted inhibitors for renal cell cancer therapy 2019
- New chromene-based molecules as microtubule destabilizers and pro-apoptotic agents in cancer 2018
- Chemical and biological characterization of chalcones and 4H-chromenes: exploitation as anticancer agents 2018
- Unraveling the anticancer molecular mechanisms of new chromene-based drugs 2018
- Discovery of chromene-based molecules as apoptosis-inducers by G2/M cell-arrest 2018
- Chromene-based drug candidates for cancer treatment 2018
- New chromene-based drug candidates for cancer treatment 2017
- Chromene derivatives as anticancer agents: synthesis and biological evaluation 2016